Blueprint Medicines Corp (BPMC)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$36.18

Buy

$90.25

arrow-up$4.07 (+4.74%)

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, BLU 554, BLU-782 and BLU-667.
Prices updated at 02 Apr 2025, 11:46 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.87%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$90.39 - $85.10
$121.90 - $80.68
-
5,752.18m
-
-
167
19.26
734,588.29
0.84
63.71m
US09627Y1091
-1.07
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.